Table II.
CENPF | |||
---|---|---|---|
Characteristic | Low (n=31) | High (n=44) | P-value |
Age (years) | 0.6410 | ||
<60 | 14 | 23 | |
≥60 | 17 | 21 | |
Sex | 0.8163 | ||
Male | 18 | 24 | |
Female | 13 | 20 | |
Smoking status | 0.6210 | ||
Smoker | 9 | 16 | |
Non-smoker | 22 | 28 | |
Tumor size | 0.0179a | ||
<5 cm | 18 | 13 | |
≥5 cm | 13 | 31 | |
TNM stage | 0.0991 | ||
I/II | 16 | 14 | |
III | 15 | 30 | |
Lymph node metastasis | 0.3474 | ||
Absent | 20 | 23 | |
Present | 11 | 21 | |
Pathological Type | 0.4705 | ||
Adenocarcinoma | 21 | 25 | |
Squamous cell carcinoma | 10 | 19 | |
Vital status (at follow-up) | 0.0008c | ||
Alive | 17 | 7 | |
Dead | 14 | 37 | |
FOXM1 expression | 0.0013b | ||
Low | 18 | 9 | |
High | 13 | 35 |
Clinicopathological features were assessed using the Fisher's exact test.
P<0.05
P<0.01
P<0.0001. NSCLC, non-small cell lung cancer; CENPF, centromere protein F; FOXM1, Forkhead box M1.